0 Commentarios
0 Acciones
614 Views
0 Vista previa
Buscar
Descubre nuevas personas, crear nuevas conexiones y hacer nuevos amigos
-
Please log in to like, share and comment!
-
Biologics & Precision Oncology: Prescription Drugs Market Set for Steady 6.76% CAGR Through 2032Global Prescription Drugs Market Poised to Surpass USD 2,444.22 Billion by 2032 Driven by Biologics Innovation, Next-Generation Targeted Therapies, and Rising Chronic Disease Prevalence The global pharmaceutical and clinical healthcare landscape is undergoing an unprecedented therapeutic and structural transformation. Driven by rapid breakthroughs in molecular biology, targeted genomics,...0 Commentarios 0 Acciones 553 Views 0 Vista previa
-
Biologics Manuuring Market Growth, Driving Factors, Strategies, Trends, Forecast Analysis By Fact.MRRockville, Maryland — October 28, 2026 The global biologics manufacturing market is projected to reach USD 225.52 billion by 2036, increasing from USD 46.92 billion in 2026 at a compound annual growth rate (CAGR) of 17.0%, according to Fact.MR. The market is expected to create an incremental opportunity of USD 178.60 billion over the forecast period, highlighting the expanding commercial...0 Commentarios 0 Acciones 289 Views 0 Vista previa
-
Biologics Market Size, Share & Growth ReportGlobal Biologics Market Poised for Exponential Growth as Targeted Therapies, Precision Oncology, and Advanced Biomanufacturing Reshape Modern Medicine 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞 @ https://www.maximizemarketresearch.com/request-sample/37255/ The global pharmaceutical landscape is experiencing an unprecedented structural shift from conventional small-molecule synthetic chemical synthesis to highly...0 Commentarios 0 Acciones 586 Views 0 Vista previa
-
Cell-Free Biologics Market Forecast Highlights 8.3% CAGR Through 2036October 3, 2026 — The Cell-Free Biologics Market is projected to reach USD 1.16 billion by 2036, rising from USD 0.53 billion in 2026 at a CAGR of 8.3%, according to Fact.MR analysis. The market was valued at USD 0.49 billion in 2025, with an absolute dollar opportunity of USD 0.63 billion expected between 2026 and 2036. The market is expanding through early-stage commercial adoption...0 Commentarios 0 Acciones 518 Views 0 Vista previa
-
Inflammatory Bowel Disease Biologics Market to Approach USD 130.8 Billion by 2036, India - CAGR 10.1%, China - CAGR 9.9%, Germany - CAGR 7.9%The inflammatory bowel disease biologics market is forecast to expand from USD 60.73 billion in 2026 to USD 130.81 billion by 2036, registering an 8.0% CAGR over the forecast period. Fact.MR attributes this expansion to the rising prevalence and diagnosis of inflammatory bowel disease, increasing adoption of biologics for moderate-to-severe cases, and the continued introduction of therapies...0 Commentarios 0 Acciones 427 Views 0 Vista previa
-
Orthopedic Trauma Devices Market – Biologics Integration Enhancing Fracture Healing in High-Risk Nonunion PopulationsMarket Overview The orthopedic trauma devices market is increasingly integrating biologics such as bone morphogenetic proteins, platelet-rich plasma, and mesenchymal stem cell concentrates to enhance fracture healing in high-risk nonunion populations. Surgeons are combining biologics with fixation devices to address biological insufficiency in smokers, diabetics, and elderly patients with...0 Commentarios 0 Acciones 560 Views 0 Vista previa
English
Arabic
French
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek
